Trump's $5 Billion AI Science Push: Big Ambition, Bigger Concerns

Key points

• The Trump administration announced 278 "Genesis Mission" grants totalling $5 billion on Thursday, all aimed at using AI to speed up scientific discovery.
• Technology companies including Google, Microsoft, and OpenAI are contributing compute power and AI credits to support the initiative.
• The White House science manifesto proposes shifting federal funding away from universities and toward individual researchers and private companies.
• Scientists and former university leaders say the plan misunderstands how basic research works and could cause lasting damage to American science.
• The manifesto explicitly proposes cutting support for "life sciences" while boosting "foundational biological sciences", two categories with heavy overlap that the document never defines.

The Trump administration unveiled its "Genesis Mission" grants Thursday, directing $5 billion toward 278 projects that use artificial intelligence to accelerate scientific discovery. The Energy Department, which led the funding round, said it will connect national laboratories, universities, and industry to pursue breakthroughs in energy, materials science, and national security. Google, Microsoft, and OpenAI are also pitching in compute time and AI credits.

At almost the same moment, Trump's science adviser Michael Kratsios was on Capitol Hill presenting a lengthy policy manifesto the White House calls the blueprint for "A New Golden Age" of American science.

What exactly is the White House proposing?

The manifesto calls for moving federal money away from universities and toward individual scientists, giving private companies a bigger role in directing research, and handing political appointees more power to block grants they disagree with. AI features throughout, as both a tool for scientists and, the document argues, an engine of discovery in its own right.

Kratsios, who has a background in tech policy and finance rather than science, framed the Genesis Mission grants as the practical expression of those ideas. He also invoked Vannevar Bush, the engineer whose 1945 report shaped America's postwar research funding system, to sell a plan that critics say would dismantle that very system.

Should scientists be worried?

Many are. Bluntly so.

"This is completely insane as an approach to reforming US science funding," Harvard's Jeffrey Flier, former dean of the university's medical school, told The Verge. He called the proposals a "major threat" and said the report "seems blissfully unaware" of the environment that scientific research needs to work.

The core complaint is that the manifesto treats science like a Silicon Valley startup. Venture capital works by picking promising people, setting clear targets, moving fast, and cutting anything that looks unlikely to pay off. Basic research, the kind that produced penicillin, the internet, and mRNA vaccines, works differently. It can take decades to matter. Its value is often invisible until suddenly it isn't.

"You cannot use venture capital to force breakthroughs while virtually already selling the patent," said Claes de Vreese, a professor of AI and society at the University of Amsterdam.

Jason Shepherd, a neurobiology professor at the University of Utah, said scientists would welcome some of what the manifesto proposes: faster peer review, more stability, better incentives for high-risk work. But he described the document as one "written by political appointees without any real consultation with scientists."

Physics professor Andreas Karch at the University of Texas at Austin put a sharper point on it. Tech leadership and scientific leadership are not the same thing, he argued, and today's scientific strength is what produces tomorrow's technological edge. "There is little evidence that our big tech companies, despite their stunning successes, can do both."

One researcher's warning was more vivid still: "We may well end up in the situation where AI will have a few major insights buried under mountains of slop, and the number of people with the experience and knowledge to tell the two apart may rapidly dwindle."

The internal contradictions trouble researchers as much as the overall direction. The manifesto proposes sharply cutting support for "life sciences" while increasing support for "foundational research in the biological sciences", but never explains where one ends and the other begins.

What should readers watch for?

If you work in or near publicly funded research, watch for grant freezes at your institution as political appointees gain broader authority to block awards. Watch for visa and student-visa restrictions that may limit the international researchers many labs depend on. And if you rely on medical or energy research, the shift away from universities toward industry partners could change which questions get asked and which get ignored.